175 related articles for article (PubMed ID: 23837015)
1. Proposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parameters.
; Cho MY; Sohn JH; Jin SY; Kim H; Jung ES; Kim MJ; Kim KM; Kim WH; Kim JM; Kang YK; Choi JH; Kang DY; Kim YW; Choi EH
Korean J Pathol; 2013 Jun; 47(3):227-37. PubMed ID: 23837015
[TBL] [Abstract][Full Text] [Related]
2. Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.
; Cho MY; Kim JM; Sohn JH; Kim MJ; Kim KM; Kim WH; Kim H; Kook MC; Park DY; Lee JH; Chang H; Jung ES; Kim HK; Jin SY; Choi JH; Gu MJ; Kim S; Kang MS; Cho CH; Park MI; Kang YK; Kim YW; Yoon SO; Bae HI; Joo M; Moon WS; Kang DY; Chang SJ
Cancer Res Treat; 2012 Sep; 44(3):157-65. PubMed ID: 23091441
[TBL] [Abstract][Full Text] [Related]
3. [Interpretation and evaluation of the American Joint committee on Cancer (AJCC) 8th Edition Staging System for patients with gastroenteropancreatic neuroendocrine tumors].
Chen L; Zhou Z; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):972-976. PubMed ID: 28900985
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
[TBL] [Abstract][Full Text] [Related]
5. Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.
Liu TC; Hamilton N; Hawkins W; Gao F; Cao D
Am J Surg Pathol; 2013 Jun; 37(6):853-9. PubMed ID: 23598967
[TBL] [Abstract][Full Text] [Related]
6. Professional Practices and Diagnostic Issues in Neuroendocrine Tumour Pathology: Results of a Prospective One-Year Survey among French Pathologists (the PRONET Study).
Scoazec JY; Couvelard A; Monges G; Guyétant S; Bisot-Locard S; Parot X; Lepage C;
Neuroendocrinology; 2017; 105(1):67-76. PubMed ID: 27442514
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
Anlauf M
Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Features of Neuroendocrine Tumors in Gastroenteropancreatic Tract: A Single Center Study.
Rafique Z; Qasim A; Zafar A; Ali S; Chughtai AS; Atiq A
Cureus; 2022 Jul; 14(7):e27384. PubMed ID: 36046310
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
10. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract][Full Text] [Related]
12. ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology.
van Velthuysen MF; Couvelard A; Rindi G; Fazio N; Hörsch D; Nieveen van Dijkum EJ; Klöppel G; Perren A
J Neuroendocrinol; 2022 Mar; 34(3):e13100. PubMed ID: 35165954
[TBL] [Abstract][Full Text] [Related]
13. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X
J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952
[TBL] [Abstract][Full Text] [Related]
14. [Pathology of neuroendocrine neoplasms].
Anlauf M; Gerlach P; Schott M; Raffel A; Krausch M; Knoefel WT; Pavel M; Klöppel G
Chirurg; 2011 Jul; 82(7):567-73. PubMed ID: 21487814
[TBL] [Abstract][Full Text] [Related]
15. [Gastroenteropancreatic neuroendocrine tumors: what must the pathologist know and do in 2014?].
Scoazec JY; Couvelard A;
Ann Pathol; 2014 Feb; 34(1):40-50. PubMed ID: 24630636
[TBL] [Abstract][Full Text] [Related]
16. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
17. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
[No Abstract] [Full Text] [Related]
18. Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors.
Fan D; Li X; Yu Y; Wang X; Fang J; Huang C
Mol Clin Oncol; 2023 Nov; 19(5):85. PubMed ID: 37809346
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
Özaslan E; Demir S; Karaca H; Güven K
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
[TBL] [Abstract][Full Text] [Related]
20. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.
Rindi G; Klöppel G; Alhman H; Caplin M; Couvelard A; de Herder WW; Erikssson B; Falchetti A; Falconi M; Komminoth P; Körner M; Lopes JM; McNicol AM; Nilsson O; Perren A; Scarpa A; Scoazec JY; Wiedenmann B; ;
Virchows Arch; 2006 Oct; 449(4):395-401. PubMed ID: 16967267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]